The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults with ...

Explore the hidden challenges faced by lung cancer patients in South Africa, where the definition of 'treatable' ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...